Adaptive Biotechnologies Corporation (ADPT) Ownership

$7.05

south_east
-$0.15 (-2.08%)
Day's range
$6.99
Day's range
$7.46

Adaptive Biotechnologies Corporation Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VIKING GLOBAL INVESTORS LP 02/14/2025 29.99 M $179.81 M   0.00% 20.33%
RUBRIC CAPITAL MANAGEMENT LP 02/14/2025 14.60 M $87.53 M   1.39% 9.90%
BLACKROCK FUNDING, INC. /DE 02/07/2025 12.12 M $72.66 M   1.58% 8.22%
VANGUARD GROUP INC 02/11/2025 10.71 M $64.24 M   0.71% 7.26%
ARK INVESTMENT MANAGEMENT LLC 02/04/2025 9.42 M $56.50 M   -18.77% 6.39%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 01/28/2025 6.83 M $40.96 M   -11.65% 4.63%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 02/10/2025 6.83 M $40.93 M   -11.65% 4.63%
MILLENNIUM MANAGEMENT LLC 02/14/2025 6.29 M $37.72 M   -33.06% 4.27%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 02/12/2025 3.37 M $20.21 M   16.99% 2.29%
SOLEUS CAPITAL MANAGEMENT, L.P. 02/14/2025 2.98 M $17.88 M   168.09% 2.02%
ARISTOTLE ATLANTIC PARTNERS, LLC 02/14/2025 2.89 M $17.31 M   -3.82% 1.96%
STATE STREET CORP 02/14/2025 2.73 M $16.37 M   6.98% 1.85%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 2.68 M $16.10 M   0.85% 1.82%
VOYA INVESTMENT MANAGEMENT LLC 02/14/2025 2.43 M $14.56 M   6,121.72% 1.65%
GOLDMAN SACHS GROUP INC 02/11/2025 2.24 M $13.42 M   27.96% 1.52%
BLUE WATER LIFE SCIENCE ADVISORS, LP 02/13/2025 2.15 M $12.86 M   0.00% 1.45%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 1.60 M $9.62 M   12.94% 1.09%
PIER CAPITAL, LLC 02/11/2025 1.27 M $7.64 M   -0.12% 0.86%
ABRDN PLC 01/24/2025 1.00 M $6.02 M   -2.47% 0.68%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 956,574 $5.73 M   4.34% 0.65%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 937,331 $5.62 M   89.17% 0.64%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/14/2025 846,171 $5.07 M   94.39% 0.57%
AMERIPRISE FINANCIAL INC 02/14/2025 736,720 $4.42 M   793.96% 0.50%
JPMORGAN CHASE & CO 02/12/2025 659,206 $3.95 M   -25.75% 0.45%
DEUTSCHE BANK AG\ 02/14/2025 630,577 $3.78 M   397.56% 0.43%
ESSEX INVESTMENT MANAGEMENT CO LLC 02/07/2025 625,838 $3.75 M   -12.92% 0.42%
CLEARLINE CAPITAL LP 02/14/2025 586,780 $3.52 M   -4.53% 0.40%
PRUDENTIAL FINANCIAL INC 02/11/2025 481,965 $2.89 M   3,290.78% 0.33%
CERITY PARTNERS LLC 02/13/2025 478,448 $2.48 M   -31.10% 0.32%
TUDOR INVESTMENT CORP ET AL 02/14/2025 458,488 $2.75 M   -11.11% 0.31%
ALGERT GLOBAL LLC 02/14/2025 430,514 $2.58 M   464.07% 0.29%
JANE STREET GROUP, LLC 02/14/2025 406,587 $2.44 M   -19.37% 0.28%
UBS GROUP AG 02/14/2025 397,258 $2.38 M   443.07% 0.27%
BANK OF NEW YORK MELLON CORP 02/04/2025 363,906 $2.18 M   -1.56% 0.25%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 354,842 $2.13 M   0.00% 0.24%
PDT PARTNERS, LLC 02/14/2025 316,281 $1.90 M   12.80% 0.21%
CUBIST SYSTEMATIC STRATEGIES, LLC 02/14/2025 315,098 $1.89 M   5.29% 0.21%
MAN GROUP PLC 02/14/2025 288,689 $1.73 M   80.01% 0.20%
BARCLAYS PLC 02/13/2025 266,066 $1.60 M   15.59% 0.18%
FMR LLC 02/13/2025 255,738 $1.53 M   9.49% 0.17%
EXODUSPOINT CAPITAL MANAGEMENT, LP 02/12/2025 246,865 $1.48 M   100.00% 0.17%
CINCTIVE CAPITAL MANAGEMENT LP 02/12/2025 241,316 $1.45 M   100.00% 0.16%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 229,785 $1.38 M   35.65% 0.16%
UBS OCONNOR LLC 02/14/2025 213,829 $1.28 M   29.38% 0.15%
AQR CAPITAL MANAGEMENT LLC 02/14/2025 212,828 $1.28 M   -18.76% 0.14%
SWISS NATIONAL BANK 02/10/2025 203,100 $1.22 M   100.00% 0.14%
TREXQUANT INVESTMENT LP 02/12/2025 185,868 $1.11 M   100.00% 0.13%
LEGATO CAPITAL MANAGEMENT LLC 01/29/2025 184,668 $1.11 M   -23.49% 0.13%
TWO SIGMA INVESTMENTS, LP 02/14/2025 183,838 $1.10 M   251.10% 0.12%
RHUMBLINE ADVISERS 01/30/2025 181,202 $1.09 M   3.05% 0.12%

Adaptive Biotechnologies Corporation institutional Ownership - FAQ's

During the previous two years, 263 institutional investors and hedge funds held shares of Adaptive Biotechnologies Corporation. The most heavily invested institutionals were:

VIKING GLOBAL INVESTORS LP: 29.99 M

Rubric Capital Management LP: 14.6 M

BlackRock Funding, Inc. /DE: 12.12 M

VANGUARD GROUP INC: 10.71 M

ARK Investment Management LLC: 9.42 M

Sumitomo Mitsui Trust Holdings, Inc.: 6.83 M

97.08% of Adaptive Biotechnologies Corporation stock is owned by institutional investors.

Institutional investors have bought a total of 159.98 M shares in the last 24 months. This purchase volume represents approximately $1.13 B in transactions.